Prenatal diagnosis of thanatophoric dysplasia by mutational analysis of the fibroblast growth factor receptor 3 gene and a proposed correction of previously published PCR results

Prenatal Diagnosis

Volumn 19, Issue 1, 1999, Pages 21-24

  Sawai, Hideaki ^a   Komori, Shinji ^a   Ida, Akinori ^a   Henmi, Takashi ^b   Bessho, Takefumi ^a   Koyama, Koji ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Kobe Adventist Hospital   (Japan)

Author keywords

Gene mutation; PCR; Prenatal diagnosis; Thanatophoric dysplasia

Indexed keywords

DNA; FIBROBLAST GROWTH FACTOR RECEPTOR; RESTRICTION ENDONUCLEASE;

ADULT; AMNION FLUID; ARTICLE; BONE DYSPLASIA; CASE REPORT; CONTROLLED STUDY; FEMALE; FETUS; GENE MUTATION; HUMAN; HYDRAMNIOS; MEDICAL DECISION MAKING; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; THANATOPHORIC DWARFISM;

EID: 0032900368     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199901)19:1<21::AID-PD457>3.0.CO;2-5     Document Type: Article

References (17)

1. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Maroteaux, P. (1996). Common mutations in the fibroblast growth factor receptor 3 (FGFR3) gene account for achondroplasia, hypochondroplasia, and thanotophoric dwarfism, Am. J. Med. Genet., 63, 148-154.
2. Goncalves, L., Jeanty, P. (1994). Fetal biometry of skeletal dysplasias: a multicentric study. J. Ultrasound Med., 13, 767-775.
3. Keegan, K., Johnson, D.E., Williams, L.T., Hayman, M.J. (1991). Isolation of an additional member of the fibroblast growth factor receptor family, FGFR3, Proc. Natl. Acad. Sci. USA, 88, 1095-1099.
4. Langer, L.O., Jr, Yang, S.S., Hall, J.G., Sommer, A., Kottamasu, S.R., Golabi, M., Krassikoff, N. (1987). Thanatophoric dysplasia and cloverleaf skull, Am. J. Med. Genet., 3 (Suppl.), 167-179.
5. Maroteaux, P., Lamy, M., Robert, J.-M. (1967). Le nanisme thanatophore, Presse Méd., 75, 2519-2524.
6. Norman, A.M., Rimmer, S., Landy, S., Donnai, D. (1992). Thanatophoric dysplasia of the straight-bone type (type 2), Clin. Dysmorphol., 1, 115-120.
7. Orioli, I.M., Castilla, E.E., Barbosa-Neto, J.G. (1986). The birth prevalence rates for the skeletal dysplasias, J. Med. Genet., 23, 328-332.
8. Perez-Castro, A.V., Wilson, J., Altherr, M.R. (1997). Genomic organization of the human fibroblast growth factor receptor 3 (FGFR3) gene and comparative sequence analysis with the mouse FGFR3 gene, Genomics, 41, 10-16.
9. Pokharel, R.K., Alimsardjono, H., Takeshima, Y., Nakamura, H., Naritomi, K., Hirose, S., Onishi, S., Matsuo, M. (1996). Japanese cases of type 1 thanatophoric dysplasia exclusively carry a C to T transition at nucleotide 742 of the fibroblast growth factor receptor 3 gene, biol. Biophys. Res. Commun., 227, 236-239.
10. Rahemtullah, A., McGillivray, B., Wilson, R.D. (1997). Suspected skeletal dysplasia: femur length to abdominal circumference ratio can be used in ultrasonographic prediction of fetal outcome, Am. J. Obstet. Gynecol., 177, 864-869.
11. Rimoin, D.L., Lachman, R.S. (1993). Genetic disorders of the osseous skeleton. In: Beighton, P. (Ed.). McKusick's Heritable Disorders of Connective Tissue, 5th edn, St Louis: Mosby, 557-689.
12. Rousseau, F., Saugier, P., Le Merrer, M., Munnich, A., Delezoide, A.-L., Maroteaux, P., Bonaventure, J. (1995). Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nature Genet., 10, 11-12.
13. Rousseau, F., Ghouzzi, V.E., Delezoide, A.L., Legeai-Mallet, L., Le Merrer, M., Munnich, A., Bonaventure, J. (1996). Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1), Hum. Mol. Genet., 5, 509-512.
14. Schild, R.L., Hunt, G.H., Moore, J., Davies, H., Horwell, D.H. (1996). Antenatal sonographic diagnosis of thanatophoric dysplasia: a report of three cases and a review of the literature with special emphasis on the differential diagnosis, Ultrasound Obstet. Gynecol., 8, 62-67.
15. Tavormina, P.L., Shiang, R., Thompson, L.M., Zhu, Y.-Z., Wilkin, D.J., Lachman, R.S., Wilcox, W.R., Rimoin, D.L., Conn, D.H., Wasmuth, J.J. (1995a). Thanatophoric dysplasia (type I and II) caused by distinct mutations in fibroblast growth factor receptor 3, Nature Genet., 9, 321-328.
16. Tavormina, P.L., Rimoin, D.L., Cohn, D.H., Zhu, Y.-Z., Shiang, R., Wasmuth, J.J. (1995b). Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I, Hum. Mol. Genet., 4, 2175-2177.
17. Tretter, A.E., Saunders, R.C., Meyers, C.M., Dungan, J.S., Grumbach, K., Sun, C.C., Campbell, A.B., Wulfsberg, E.A. (1998). Antenatal diagnosis of lethal skeletal dysplasia, Am. J. Med. Genet., 75, 518-522.